Phathom Pharmaceuticals, Inc. · NASDAQ:PHAT

James N. Topper reported a 8.60% stake in Phathom Pharmaceuticals, Inc. (Schedule 13D/A)

Event Aug 18, 2025 · Filed Aug 20, 2025

James N. Topper reported a 8.60% stake in Phathom Pharmaceuticals, Inc., 5,985,327 shares, with active intent on Aug 18, 2025. Filed Aug 20, 2025 (Schedule 13D/A).

Stake
8.60%
Shares
5,985,327
Intent
Active
What changed
Stake changed
Filed together
23 holders

The filing in full

HolderStakeShares
Frazier Life Sciences Public Fund, L.P.6.00%4,234,991
FHMLSP, L.P.6.00%4,234,991
FHMLSP, L.L.C.6.00%4,234,991
Frazier Life Sciences Public Overage Fund, L.P.1.60%1,088,365
FHMLSP Overage, L.P.1.60%1,088,365
FHMLSP Overage, L.L.C.1.60%1,088,365
Frazier Life Sciences X, L.P.0.10%59,403
FHMLS X, L.P.0.10%59,403
FHMLS X, L.L.C.0.10%59,403
Frazier Life Sciences XI, L.P.1.40%980,286
FHMLS XI, L.P.1.40%980,286
FHMLS XI, L.L.C.1.40%980,286
Frazier Life Sciences IX, L.P.8.20%5,827,415
FHMLS IX, L.P.8.20%5,827,415
FHMLS IX, L.L.C.8.20%5,827,416
Frazier Life Sciences XII, L.P.0.40%276,029
FHMLS XII, L.P.0.40%276,029
FHMLS XII, L.L.C.0.40%276,029
James N. Topper8.60%5,985,327
Patrick J. Heron8.40%5,901,756
Albert Cha0%0
James Brush0%0
Daniel Estes0%0

Source

View original at SEC

Related